Efficacy of Mesenchymal Stromal Cell Therapy for Acute Lung Injury in Preclinical Animal Models: A Systematic Review.

The Acute Respiratory Distress Syndrome (ARDS) is a devastating clinical condition that is associated with a 30-40% risk of death, and significant long term morbidity for those who survive. Mesenchymal stromal cells (MSC) have emerged as a potential novel treatment as in pre-clinical models they hav...

Полное описание

Библиографические подробности

Главные авторы:	Lauralyn A McIntyre, David Moher, Dean A Fergusson, Katrina J Sullivan, Shirley H J Mei, Manoj Lalu, John Marshall, Malcolm Mcleod, Gilly Griffin, Jeremy Grimshaw, Alexis Turgeon, Marc T Avey, Michael A Rudnicki, Mazen Jazi, Jason Fishman, Duncan J Stewart, Canadian Critical Care Translational Biology Group
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Public Library of Science (PLoS) 2016-01-01
Серии:	PLoS ONE
Online-ссылка:	https://doi.org/10.1371/journal.pone.0147170
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!